ON THE NATURE OF THE FOLLICLE-STIMULATING SIGNAL DELIVERED TO THE OVARY DURING EXOGENOUSLY CONTROLLED FOLLICULAR MATURATION - A SEARCH INTOTHE IMMUNOLOGICAL AND BIOLOGICAL ATTRIBUTES AND THE MOLECULAR COMPOSITION OF 2 PREPARATIONS OF UROFOLLITROPIN
A. Ulloaaguirre et al., ON THE NATURE OF THE FOLLICLE-STIMULATING SIGNAL DELIVERED TO THE OVARY DURING EXOGENOUSLY CONTROLLED FOLLICULAR MATURATION - A SEARCH INTOTHE IMMUNOLOGICAL AND BIOLOGICAL ATTRIBUTES AND THE MOLECULAR COMPOSITION OF 2 PREPARATIONS OF UROFOLLITROPIN, Archives of medical research, 26, 1995, pp. 219-230
In the present study, we analyzed the immunological and biological pot
encies as well as the molecular composition of urinary follicle-stimul
ating hormone (FSH) present in determined lots of regular and highly p
urified (HP) commercial preparations of urofollitropin in order to obt
ain additional insights on the particular type of gonadotropin signal
received by the ovary during exogenously regulated ovarian stimulation
. In both preparations, a high degree of FSN charge heterogeneity was
detected as disclosed by chromatofocusing analysis (pH range 7.5 to <4
.0), Urinary FSH present in the HP compound was consistently more acid
ic and exhibited a longer survival in rat circulation than the regular
formulation. Inter-batch variability for FSH heterogeneity and in vit
ro bioactivity was higher in the partially purified preparation than i
n the HP analog. In the regular preparation, the amount of immunoreact
ive and bioactive FSH per ampule was two times higher than that presen
t in the HP preparation; the resultant in vitro B/I ratios were simila
r. Although both urinary FSH preparations showed detectable amounts of
immunoreactive and bioactive luteinizing hormone and choriogonadotrop
in hormone material, the degree of activity present in the less purifi
ed formulation was considerably higher than that shown by the HP analo
g. When the capability of each urinary FSH preparation to induce ovari
an tissue-type plasminogen activator enzyme activity in hypophysectomi
zed rats was determined, both formulations exhibited similar potencies
despite the existing differences in plasma clearance rate and charge
distribution profile. The present study indicates that the isoform com
position of urinary FSH in the two commercial preparations analyzed di
ffers according to the degree of purity of the formulation. More FSH m
aterial is needed in the partially purified FSH preparation to induce
biological effects similar in magnitude to those exhibited by the high
ly purified analog. The possible impact of these variations in the mol
ecular composition of the FSH signal on other biological functions of
the ovary during the course of exogenously controlled follicular growt
h and maturation still remains to be ascertained.